Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Alamar Biosciences, Inc.NASDAQ: ALMR

Change in Working Capital · Q2 FY2026 · quarter ended Jun 2026

Change in working capital of -$4.78M in Q2 FY2026

Q2 FY2026 change in working capital was -$4.78M.

Context

  • Change in working capital amounted to 43.9% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$4.78M-58.0% QoQ
Last fiscal yearDec 2025
-$32.57M— YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
(32.57M) USD
Year-over-year change
—

Change in Working Capital vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 change in working capital of $32.57M is the 4th largest of the 9 companies compared; the peer median is $4.15M.
  • Change in working capital amounts to 43.9% of revenue for ALMR, versus a peer median of 8.4%.
ALMR Competitors Peer median
Change in Working Capital for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LABStandard BioTools Inc.LTM Mar 2026$87.08M +302.5%+53.8%101.0%
TECHBio-Techne CorporationLTM Sep 2026$67.36M +412.2%-23.0%5.5%
TXG10x Genomics, Inc.LTM Jun 2026$51.58M +474.0%—8.4%
ALMRAlamar Biosciences, Inc.FY2025$32.57M ——43.9%
TWSTTwist Bioscience CorporationLTM Sep 2026$15.56M +23.4%+98.0%3.4%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$10M +156.8%—6.2%
QSIQuantum-Si incorporatedLTM Mar 2026$6.69M -276.3%—361.1%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$4.18M -8.0%+65.7%—
SEERSeer, Inc.LTM Mar 2026$4.12M +8308.2%-56.6%27.4%
Peer median (excluding ALMR) $4.15M+229.6%+53.8%8.4%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.